Study S001725

Autologous Hematopoietic Stem Cell Mobilization (Plerixafor) and Immunologic Reset in New Onset Type 1 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03182426
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1; PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 22
Start: 2017-08-15
Primary completion: 2024-07-15
Lead sponsor: University of Alberta
Conditions: Diabetes Mellitus, Type 1
Interventions: DRUG:Plerixafor; DRUG:Alemtuzumab; DRUG:Anakinra; DRUG:Etanercept; DRUG:Liraglutide
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Change of 2-hour mixed meal stimulated C-peptide AUC [Baseline, Month 3, 6, 9, 12, 18 and 24]
Rate of Serious Adverse Event/Medical Event of Special Interest [Within 24 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.